About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

TERMINATEDNANCT01553929

Physical Training and Cognitive Activity on the Mild Cognitive Impairment (MCI) Patient

Regular physical activity is now recognized as a key element of good physical and mental health and this all ages. MAIN GOAL : Evaluate the effectiveness of physical training associated with a cognit...

Lead sponsor: Centre Hospitalier Universitaire de Nice•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Centre Hospitalier Universitaire de Nice

Age

40 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Diagnosed patient MCI (Mild Cognitive Impairment)
•Elderly from 40 to 75 years old
•MMSE upper to 22
•Affiliated or beneficiary of a national insurance scheme
•Medical capacity to the physical proposed activity (filling of the conditions of the Medical certificate of not contraindication in the sport)

Exclusion Criteria

•The placed persons under guardianship, under protection of justice,
•The private persons of freedom (administrative or judicial)
•Nobody already participating in a clinical trial

Related studies

Blood-based Biomarkers for Alzheimer's Disease at the Primary Care Level.

NCT07666113 · Alzheimer's Disease (AD)

Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment (COGNIKET-MCI)

NCT06347315 · Mild Cognitive Impairment

rTMS Combined With Aerobic Exercise for Older Adults With Mild Cognitive Impairment and Comorbid Depression

NCT07652775 · Mild Cognitive Impairment (MCI), Depressive Symptoms

RECRUITINGPhase 1

A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease

NCT07214727 · Alzheimer's Disease

RECRUITINGPhase 2

A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

NCT06745583 · Mild, Moderate, or Severe Alzheimer's Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 14, 2015Terms

Trial snapshot

StatusTERMINATED

PhaseNA

Enrollment5

Start dateMar 2012

Last updatedAug 14, 2015

Condition

Mild Cognitive Impairment Alzheimer's Disease

Locations shown

CHU de Nice

Nice

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 14, 2015Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions